Selective Internal Radiation Therapy with 90Yttrium Microspheres for Primary or Metastatic Cancer Confined to the Liver
Selective Internal Radiation Therapy with 90Yttrium Microspheres for Primary or Metastatic Cancer Confined to the Liver
复制标题
使用 90 钇微球选择性体内放射治疗局限于肝脏的原发性或转移性癌症
DOI：
10.1007/978-1-4615-0547-1_24
复制
发表时间：
2002
期刊：
影响因子：
2.6
通讯作者：
R. Cannan
中科院分区：
文献类型：
--
作者：
R. Stubbs;R. Cannan
肝癌每年在世界范围内造成40多万人死亡，使其成为癌症死亡的第四大常见原因。它的死亡率特别高，总死亡率与发病率之比为0.98:11。原发性肝细胞癌是世界范围内最常见的癌症，如果没有成功的治疗，从诊断到预后只有3-6个月。大多数形式的癌症最终会在死亡前扩散到肝脏，但对于结直肠肝转移的患者，死亡往往没有肝外疾病的证据。诊断为结直肠肝转移的患者的预期生存期为6-12个月，取决于肝脏受累程度。
Liver cancer is responsible for over 400,000 deaths per year world-wide, making it the fourth most common cause of death from cancer. It has a particularly high fatality rate with an overall mortality to incidence ratio of 0.98:11. Primary hepatocellular cancer is the most common cancer occurring World-wide and has a prognosis of only 3-6 months from diagnosis without successful treatment. Most forms of cancer will ultimately spread to the liver before death occurs but for patients with colorectal liver metastases, death frequently occurs without there being evidence of disease outside the liver. Expected survival for those diagnosed with colorectal liver metastases is of the order of 6-12 months, depending on the extent of liver involvement.
使用含钇 90 的玻璃微球进行肝脏放射栓塞：初步结果和临床随访。
DOI：
--
发表时间：
1994
期刊：
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
影响因子：
--
作者：
Andrews,JC;Walker,SC;Ackermann,RJ;Cotton,LA;Ensminger,WD;Shapiro,B
通讯作者：
Shapiro,B